NASDAQ:SMTI Sanara MedTech Q3 2026 Earnings Date & Estimates $32.79 -0.09 (-0.27%) As of 10/23/2026 04:00 PM Eastern This is a fair market value price provided by Massive. Learn more. Sanara MedTech is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026. The conference call is scheduled for November 9, 2026 at 4:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 11, 2026Conference Call DateNovember 9, 2026Conference Call4:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Sanara MedTech in Q3 2026Sanara MedTech is expected to post earnings of $0.06 per share on revenue of $29.67 million. In the same quarter a year earlier Sanara MedTech reported $0.09 per share on revenue of $26.33 million. Sanara MedTech last reported on August 11, 2026, posting -$0.05 per share and missing the -$0.0250 consensus estimate. Sanara MedTech has beaten the consensus EPS estimate in 4 of its last 7 quarters.Consensus EstimatesConsensus EPS$0.06Expected Revenue$29.67 millionPrior-Year EPS$0.09Prior-Year Revenue$26.33 millionExpected EPS Growth-33.3%Expected Revenue Growth+12.7%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.05 (Missed by -$0.0250)Last Quarter Revenue$28.14 millionEPS Beat Rate4 of last 7 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ4 2025 Earnings ReportQ3 2025 Earnings Report Sanara MedTech Q3 2026 Earnings FAQ When does Sanara MedTech report Q3 2026 earnings? Sanara MedTech (NASDAQ:SMTI) is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Sanara MedTech's Q3 2026 earnings call? Sanara MedTech's Q3 2026 earnings conference call is scheduled for Monday, November 9, 2026 at 4:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Sanara MedTech? Analysts expect Sanara MedTech to post earnings of $0.06 per share for Q3 2026. How much revenue is Sanara MedTech expected to report? The consensus revenue estimate for Sanara MedTech is $29.67 million for Q3 2026. Sanara MedTech Earnings HeadlinesSanara MedTech (NASDAQ:SMTI) vs. Hyperfine (NASDAQ:HYPR) Critical ReviewOctober 20, 2026 | americanbankingnews.comSanara MedTech/MiMedx deal spread widens on FTC second requestOctober 16, 2026 | seekingalpha.comThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.October 25 at 1:00 AM | Porter & Company (Ad)Sanara MedTech merger faces extended FTC reviewOctober 16, 2026 | tipranks.comMiMedx Group merger delayed amid extended FTC reviewOctober 16, 2026 | tipranks.comSanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTISeptember 10, 2026 | businesswire.comSee More Sanara MedTech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sanara MedTech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sanara MedTech and other key companies, straight to your email. Email Address About Sanara MedTechSanara MedTech (NASDAQ:SMTI) is a medical technology company focused on developing, commercializing and distributing products used in wound care, surgical soft-tissue repair and tissue regeneration. The company serves healthcare providers treating acute, chronic and complex wounds, as well as patients requiring surgical tissue management. Sanara’s product portfolio includes advanced wound-care and tissue-repair technologies such as CellerateRX products, FORTIFY tissue-repair products and other regenerative medicine solutions. These products are designed to support wound management, help maintain a suitable healing environment and assist with the repair of damaged or compromised tissue. Based in Fort Worth, Texas, Sanara markets its products primarily through healthcare channels serving hospitals, outpatient facilities, physicians and post-acute care providers in the United States. The company’s strategy centers on expanding the adoption of clinically focused products that address unmet needs in wound care and surgical tissue repair.View Sanara MedTech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a PipelineLockheed Martin’s Record $292 Billion Backlog Comes With a Delivery TestCan Planet Fitness Get Its Growth Back in Shape?Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating CostsWhy Western Digital's AI Storage Boom Defies the Chip Sell-Off Upcoming Earnings Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Coca Cola Femsa (10/27/2026)Baker Hughes (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
